Plasminogen activator inhibitor (PAI)-1, Adiponectin, retinol-binding protein-4 (RBP4), chemerin, and adipocyte fatty-acid-binding protein (A-FABP) have been suggested as potential biomarkers for insulin resistance. The gene discussed is RBP4; the disease is Insulin resistance.